[go: up one dir, main page]

DE69810024D1 - Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten - Google Patents

Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten

Info

Publication number
DE69810024D1
DE69810024D1 DE69810024T DE69810024T DE69810024D1 DE 69810024 D1 DE69810024 D1 DE 69810024D1 DE 69810024 T DE69810024 T DE 69810024T DE 69810024 T DE69810024 T DE 69810024T DE 69810024 D1 DE69810024 D1 DE 69810024D1
Authority
DE
Germany
Prior art keywords
allergy
treatment
type
related diseases
immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69810024T
Other languages
English (en)
Other versions
DE69810024T2 (de
Inventor
Hitoshi Oomori
Yoichi Ooiso
Ryosuke Sugihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tayca Corp
Original Assignee
Tayca Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tayca Corp filed Critical Tayca Corp
Publication of DE69810024D1 publication Critical patent/DE69810024D1/de
Application granted granted Critical
Publication of DE69810024T2 publication Critical patent/DE69810024T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69810024T 1997-01-07 1998-01-05 Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten Expired - Fee Related DE69810024T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9013125A JPH10194979A (ja) 1997-01-07 1997-01-07 イムノグロブリンｅ抗体産生抑制剤
PCT/JP1998/000029 WO1998030224A1 (en) 1997-01-07 1998-01-05 Inhibitor of immunoglobulin e antibody production

Publications (2)

Publication Number Publication Date
DE69810024D1 true DE69810024D1 (de) 2003-01-23
DE69810024T2 DE69810024T2 (de) 2003-09-25

Family

ID=11824450

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69810024T Expired - Fee Related DE69810024T2 (de) 1997-01-07 1998-01-05 Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten

Country Status (6)

Country Link
US (1) US6423320B1 (de)
EP (1) EP0894001B1 (de)
JP (1) JPH10194979A (de)
AT (1) ATE229339T1 (de)
DE (1) DE69810024T2 (de)
WO (1) WO1998030224A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003056500A1 (en) 2001-12-24 2003-07-10 Digimarc Id Systems, Llc Covert variable information on id documents and methods of making same
WO2003088144A2 (en) 2002-04-09 2003-10-23 Digimarc Id Systems, Llc Image processing techniques for printing identification cards and documents
US20100111927A1 (en) * 2002-08-23 2010-05-06 Sunyoung Kim Compositions Comprising Actinidia and Methods of Use Thereof
KR100615389B1 (ko) * 2002-08-23 2006-08-25 (주)헬릭서 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
JP5737646B2 (ja) * 2010-03-24 2015-06-17 森下仁丹株式会社 抗アレルギー剤
US10688169B2 (en) 2015-03-27 2020-06-23 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccines against carbapenem-resistant Klebsiella pneumoniae

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870053A (en) * 1980-09-19 1989-09-26 Roussel Uclaf Novel compositions and processes
US4755381A (en) * 1986-03-27 1988-07-05 Swiss Serum And Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine
ATE72401T1 (de) * 1986-03-27 1992-02-15 Schweiz Serum & Impfinst Impfstoff des klebsiella kapsulpolysaccharids.
FR2620130B1 (fr) 1987-09-08 1990-01-12 Lipha Nouveaux polysaccharides hydrosolubles, leur procede d'obtention, leur application a titre de medicaments et preparation les renfermant
KR920701341A (ko) * 1989-05-04 1992-08-11 미리엄 디이 데코너헤이 폴리염화비닐용 중합가소제
JPH0790003A (ja) * 1993-03-01 1995-04-04 Teika Corp 新規多糖類、その製造方法、新規多糖類の用途およびアゾトバクター・ベイジェリンキィーｔｎｍ１株
JP3453192B2 (ja) * 1994-06-01 2003-10-06 テイカ株式会社 新規多糖類、その製造方法、新規多糖類の用途およびアグロバクテリウム・ラディオバクターｔｎｍ２株
US5989874A (en) * 1995-03-27 1999-11-23 Tayca Corporation Humectant, antistatic agent, dispersant and film-forming agent having polysaccharide as active principle, preparation process of polysaccharides, and Kliebsiella ocytoca TNM-3 strain
WO1996039155A1 (en) * 1995-06-05 1996-12-12 Tayca Corporation Immunopotentiator

Also Published As

Publication number Publication date
EP0894001B1 (de) 2002-12-11
JPH10194979A (ja) 1998-07-28
ATE229339T1 (de) 2002-12-15
US20020041885A1 (en) 2002-04-11
WO1998030224A1 (en) 1998-07-16
EP0894001A1 (de) 1999-02-03
US6423320B1 (en) 2002-07-23
DE69810024T2 (de) 2003-09-25

Similar Documents

Publication Publication Date Title
ATE283264T1 (de) Zwischenprodukte zur herstellung von metallproteinasehemmern
ES2062812T3 (es) Composicion detergente enzimatica y metodo para estabilizar enzimas.
ES2163644T3 (es) Procedimiento para la estabilizacion de proteinas en un medio acido con una pectina muy esterificada.
ATE287946T1 (de) Neuartige lipasevarianten zur verwendung in reinigungsmitteln
DE69632630D1 (de) Enzym mit aminopeptidaseactivität
MX9705005A (es) Inhibidores de la proteina de transferencia de trigliceridos microsomicos y metodo.
ATE490311T1 (de) Mutanten der alpha-amylase
ITTO930838A1 (it) Sistema di registraziome per una linea di produzione.
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
ATE279922T1 (de) Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc
AU8581991A (en) Mercaptoacetylamide derivatives as inhibitors of enkephalinase and ACE, and processes for their production
NO952989D0 (no) Fremgangsmåte til refolding av proteiner
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
DE69832489D1 (de) Induktion von männlicher sterilität in pflanzen durch erhöhte expression von streptavidin
NO942994D0 (no) Aminoacetylmercaptoacetylamidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
JP2001515920A5 (de)
DE69810024D1 (de) Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten
DE69736975D1 (de) Enzym mit galaktanaseaktivität
ATE217153T1 (de) Verwendung von galactanase in tierfutter
BG100248A (bg) Инхибитори на скваленсинтетаза
DE69917445D1 (de) Reinigung von carboxaldehyd
NO920163L (no) Hydrolysert vegetabilsk protein og fremstilling av et slikt
EP0663210A3 (de) Hemmer der Produktion von Tumornekrosefaktoren.
DE69331094D1 (de) Verfahren zur Herstellung von essfertigen Getreideflocken
UA34504C2 (uk) Виробництво часток та виробів із запроектованими властивостями

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee